HER2 Support Group Forums - View Single Post - I promised a reference for which talk at ASCO discussed the diminishing returns for

Lani · 06-30-2010, 02:14 PM

2nd,3rd, 4th,and so on line chemotherapy for recurrent metastatic breast cancer and how that differed for her2 targeted therapies for her2+ patients.

It was from

Therapeutic Options for Treatment Refractory Breast Cancer: Discussion
Harold J. Burstein, MD, PhD
Discussant

Given on the last day of ASCO

It is a video included in the virtual meeting which will be available free @ the beginning of December.

06-30-2010, 02:14 PM	#1
Lani Senior Member Join Date: Mar 2006 Posts: 4,783	I promised a reference for which talk at ASCO discussed the diminishing returns for 2nd,3rd, 4th,and so on line chemotherapy for recurrent metastatic breast cancer and how that differed for her2 targeted therapies for her2+ patients. It was from Therapeutic Options for Treatment Refractory Breast Cancer: Discussion Harold J. Burstein, MD, PhD Discussant Given on the last day of ASCO It is a video included in the virtual meeting which will be available free @ the beginning of December.